A型急性主动脉综合征的非手术治疗:系统综述与Meta分析
该系统综述与Meta分析评估保守治疗在A型急性主动脉综合征患者中的影响。纳入29项研究共6894例患者,A型主动脉夹层保守治疗院内死亡率39.1%,A型壁内血肿为7.2%,部分患者转为手术治疗。
要点
- A型主动脉夹层保守治疗院内死亡率高达39.1%。
- A型壁内血肿保守治疗院内死亡率7.2%,但异质性大。
- 部分保守治疗患者转为手术,夹层组20.7%,血肿组26.3%。
核心结论
- 保守治疗的A型主动脉夹层患者死亡率仍高。
- 壁内血肿保守治疗类型异质性大,无法对其安全性和有效性做出确切结论。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA指南。
- 检索MEDLINE、Embase和Cochrane Library,纳入29项研究共6894例患者。
- 采用Newcastle-Ottawa量表进行偏倚风险评估。
主要发现
- A型主动脉夹层保守治疗全因院内死亡合并比例39.1%(95%CI 29.8-48.9%;I2=90.1%)。
- A型主动脉夹层保守治疗全因30天死亡合并比例31.1%(95%CI 8.8-59.1%;I2=95.9%)。
- A型主动脉夹层保守转手术比例20.7%(95%CI 0.0-61.7%;I2=93.4%)。
- A型壁内血肿保守治疗全因院内死亡合并比例7.2%(95%CI 2.6-13.4%;I2=76.5%)。
- A型壁内血肿保守治疗全因30天死亡合并比例15.3%(95%CI 1.1-37.9%;I2=64.1%),保守转手术比例26.3%(95%CI 12.1-43.4%;I2=90.5%)。
临床怎么用
- 对无法手术的A型主动脉夹层患者,保守治疗死亡率高,需谨慎评估。
- 壁内血肿保守治疗异质性大,决策应个体化。
局限性
- 壁内血肿保守治疗类型异质性大,限制结论可靠性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: For type A acute aortic syndrome (TAAAS), the only alternative for patients who are contraindicated for open surgery or endovascular interventions is medical therapy. The objective of this study was to assess the impact of conservative treatment in patients suffering TAAAS. METHODS: This systematic review and meta-analysis was performed according to the PRISMA guidelines. A systematic search was conducted on MEDLINE, Embase, and the Cochrane Library for relevant studies. Pairwise meta-analysis was conducted to compare surgical with medical intervention. Included studies were subjected to risk of bias assessment using the Newcastle-Ottawa scale. RESULTS: Twenty-nine studies comprising 6894 patients were included. For patients with type A aortic dissection (TAAD), the pooled proportions of all cause in hospital mortality and all cause 30 day mortality were 39.1% (95% confidence interval [CI] 29.8-48.9%; I2 = 90.1%), and 31.1% (95% CI 8.8-59.1%; I2 = 95.9%), respectively. There was a significant proportion of patients who converted from medical to surgical treatment (20.7%, 95% CI 0.0-61.7%; I2 = 93.4%). In patients with type A intramural haematoma (IMH), the pooled proportions of all cause in hospital mortality and all cause 30 day mortality were 7.2% (95% CI 2.6-13.4%; I2 = 76.5%) and 15.3% (95% CI 1.1-37.9%; I2 = 64.1%). A significant proportion of patients converted from medical to surgical treatment (26.3%, 95% CI 12.1-43.4%; I2 = 90.5%). CONCLUSION: Mortality remains high for conservatively treated patients with TAAD. For patients with IMH, heterogeneity in the types of conservative treatment prohibit any firm conclusion regarding its safety and efficacy.
引用
- Wee I, Varughese RS, Syn N, et al. Non-operative Management of Type A Acute Aortic Syndromes: A Systematic Review and Meta-Analysis. Eur J Vasc Endovasc Surg. 2019. PMID: 31178357. doi:10.1016/j.ejvs.2018.10.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。